Search Results - "Schanberg, L E"

Use of atorvastatin in systemic lupus erythematosus in children and adolescents by Schanberg, L. E., Sandborg, C., Barnhart, H. X., Ardoin, S. P., Yow, E., Evans, G. W., Mieszkalski, K. L., Ilowite, N. T., Eberhard, A., Imundo, L. F., Kimura, Y., von Scheven, E., Silverman, E., Bowyer, S. L., Punaro, M., Singer, N. G., Sherry, D. D., McCurdy, D., Klein-Gitelman, M., Wallace, C., Silver, R., Wagner-Weiner, L., Higgins, G. C., Brunner, H. I., Jung, L., Soep, J. B., Reed, A. M., Provenzale, J., Thompson, S. D.

“…Objective Statins reduce atherosclerosis and cardiovascular morbidity in the general population, but their efficacy and safety in children and adolescents with…”
Get full text

Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein I by Wahezi, DM, Ilowite, NT, Wu, XX, Pelkmans, L, Laat, B, Schanberg, LE, Rand, JH

“…Children with systemic lupus erythematosus (SLE) have a high prevalence of antiphospholipid (aPL) antibodies and are at increased risk for aPL-related…”
Get full text

Family Pain History Predicts Child Health Status in Children With Chronic Rheumatic Disease by Schanberg, Laura E, Anthony, Kelly K, Gil, Karen M, Lefebvre, John C, Kredich, Deborah W, Macharoni, Lisa M

“…To examine the relationships of parental and family pain history on the pain experience of children with chronic rheumatic disease. The aims of the study were…”
Get full text

Evaluating anchor variables and variation in meaningful score differences for PROMIS ® Pediatric measures in children and adolescents living with a rheumatic disease by Zigler, C K, Li, Z, Hernandez, A, Randell, R L, Mann, C M, Weitzman, E, Schanberg, L E, von Scheven, E, Reeve, B B

“…Meaningful score differences (MSDs), as defined by recent FDA guidance, can improve the interpretation of outcome measure scores and score changes…”
Get full text

Management of dyslipidemia in children and adolescents with systemic lupus erythematosus by Ardoin, S P, Sandborg, C, Schanberg, L E

“…Systemic lupus erythematosus (SLE) is an independent risk factor for atherosclerosis, placing children and adolescents with SLE at great risk for developing…”
Get full text

Identifying clinically meaningful severity categories for PROMIS pediatric measures of anxiety, mobility, fatigue, and depressive symptoms in juvenile idiopathic arthritis and childhood-onset systemic lupus erythematosus by Mann, C. M., Schanberg, L. E., Wang, M., von Scheven, E., Lucas, N., Hernandez, A., Ringold, S., Reeve, B. B.

“…Purpose A key limitation to widespread adoption of patient-reported outcome (PRO) measures is the lack of interpretability of scores. We aim to identify…”
Get full text

Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort by Ardoin, SP, Schanberg, LE, Sandborg, C., Yow, E., Barnhart, HX, Mieszkalski, KL, Ilowite, NT, von Scheven, E., Eberhard, A., Levy, DM, Kimura, Y., Silverman, E., Bowyer, SL, Punaro, L., Singer, NG, Sherry, DD, McCurdy, D., Klein-Gitelman, M., Wallace, C., Silver, R., Wagner-Weiner, L., Higgins, GC, Brunner, HI, Jung, LK, Imundo, L., Soep, JB, Reed, AM

“…As part of the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Trial, a prospective multicenter cohort of 221 children and adolescents with…”
Get full text

Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus by Wu, E Y, Schanberg, L E, Wershba, E C, Rabinovich, C E

“…Objective Cutaneous manifestations of pediatric systemic lupus erythematosus cause significant morbidity. Lenalidomide, a thalidomide analogue, has shown…”
Get full text

Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa by Lewandowski, L B, Schanberg, L E, Thielman, N, Phuti, A, Kalla, A A, Okpechi, I, Nourse, P, Gajjar, P, Faller, G, Ambaram, P, Reuter, H, Spittal, G, Scott, C

“…Background Systemic lupus erythematosus (SLE) is a life-threatening multisystem autoimmune disease that is more severe in patients of African ancestry and…”
Get full text

Social Context of Pain in Children with Juvenile Primary Fibromyalgia Syndrome: Parental Pain History and Family Environment by Schanberg, Laura E, Keefe, Francis J, Lefebvre, John C, Kredich, Deborah W, Gil, Karen M

“…OBJECTIVE:The purpose of this study was to describe parental pain history and the family environment as it relates to the functional status of children with…”
Get full text

Annexin A5 anticoagulant activity in children with systemic Lupus erythematosus and the association with antibodies to domain I of beta 2-glycoprotein I by Wahezi, D M, Ilowite, N T, Wu, X X, Pelkmans, L, Laat, B, Schanberg, LE, Rand, J H

“…Children with systemic Lupus erythematosus (SLE) have a high prevalence of antiphospholipid (aPL) antibodies and are at increased risk for aPL-related…”
Get full text

The relationship of daily mood and stressful events to symptoms in juvenile rheumatic disease by SCHANBERG, L. E, SANDSTROM, M. J, STARR, K, GIL, K. M, LEFEBVRE, J. C, KEEFE, F. J, AFFLECK, G, TENNEN, H

“…The purpose of this study was 3-fold: 1) to assess the feasibility of a daily diary for use with children with juvenile rheumatic disease (JRD), 2) to describe…”
Get full text

Causes of pain in children with arthritis by Schanberg, L E, Sandstrom, M J

“…Pain in children with juvenile rheumatoid arthritis (JRA) is often not fully recognized and is therefore incompletely treated. The use of pain assessment…”
Get more information

Isolation and Characterization of the Genomic Human CD7 Gene: Structural Similarity with the Murine Thy-1 Gene by Schanberg, Laura E., Fleenor, Donald E., Kurtzberg, Joanne, Haynes, Barton F., Kaufman, Russel E.

“…The human CD7 molecule is a 40-kDa member of the immunoglobulin gene superfamily that is expressed on T-lymphoid and myeloid precursors in fetal liver and bone…”
Get full text

Juvenile primary fibromyalgia syndrome by Anthony, K K, Schanberg, L E

“…Juvenile primary fibromyalgia syndrome (JPFS) is a common musculoskeletal pain syndrome of unknown etiology characterized by widespread persistent pain, sleep…”
Get full text

Review: Management of dyslipidemia in children and adolescents with systemic lupus erythematosus by Ardoin, SP, Sandborg, C., Schanberg, LE

“…Systemic lupus erythematosus (SLE) is an independent risk factor for atherosclerosis, placing children and adolescents with SLE at great risk for developing…”
Get full text

Pain coping and the pain experience in children with juvenile chronic arthritis by Schanberg, Laura E, Lefebvre, John C, Keefe, Francis J, Kredich, Deborah W, Gil, Karen M

“…This study examined the pain experience and pain coping of children with juvenile chronic arthritis (JCA). The purpose of the study was to describe present…”
Get more information

Prevention of leg length discrepancy in young children with pauciarticular juvenile rheumatoid arthritis by treatment with intraarticular steroids by Sherry, David D., Stein, Leonard D., Reed, Ann M., Schanberg, Laura E., Kredich, Deborah W.

“…Objective To determine if intraarticular (IA) injection of triamcinolone hexacetonide (steroids) used early in the course of pauciarticular juvenile rheumatoid…”
Get full text

Pediatric Pain Syndromes and Management of Pain in Children and Adolescents with Rheumatic Disease by Anthony, Kelly K., Schanberg, Laura E.

“…This article introduces important issues related to pain in children with musculoskeletal pain syndromes and rheumatic disease, using juvenile primary…”
Get full text

Daily sleep quality and mood as predictors of pain in children with juvenile polyarticular arthritis by Bromberg, MH, Gil, KM, Schanberg, LE

Get full text